We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.50 | 3.57% | 14.50 | 14.00 | 15.00 | 15.00 | 14.00 | 14.00 | 1,143,844 | 10:04:36 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 1.04M | -21.69M | -0.0832 | -1.74 | 37.78M |
Date | Subject | Author | Discuss |
---|---|---|---|
26/4/2024 10:02 | Five trades reported as sells which look like a cunningly disguised rollover | donald pond | |
26/4/2024 10:00 | Until the sell on the spike pack start selling. They have bought at 13.5p so soon they will go for the profit then rinse and repeat. | robizm | |
26/4/2024 09:58 | This is going to rocket | kirk 6 | |
26/4/2024 09:37 | in the top 25 gainers on the leaderboard moving up nicely and mms ready to tick up again | citys2874 | |
26/4/2024 09:26 | Wait for results imo | washingmachine | |
26/4/2024 09:25 | Thats too much information for her tiny brain | zeus19 | |
26/4/2024 09:13 | @699 maybe highlight the caveat to this 'tiny deal' - as the below means nothing does it: The collaboration gives ANGLE the POTENTIAL to EXPAND their services in oncology trials. The initial phase of the contract is valued at £150,000, but it holds SUBSTANTIAL POTENTIAL due to the possibility of implementing a new assay in NUMEROUS cancer TRIALS involving AstraZeneca. Furthermore, the collaboration includes the development of assays for examining proteins on cancer cells across multiple trials, with POTENTIAL EARNINGS of £2,000 per time point in over 460 trials involving 140,000 patients. ?140,000 patients x £2,000 = £280M ?£280M x 3 time points = £840M-In effect ANGLE have opened the door to a 840 MILLION QUID BUSINESS OPPORTUNITY with just AstraZeneca. Want to do the maths on EISAI trials too? | 5oletrader | |
26/4/2024 09:06 | Results due soonish? | boris cobaka | |
26/4/2024 09:02 | In the top 40 gainers now on the leaderboard and mms are ready to tick up once again | citys2874 | |
26/4/2024 09:01 | Looking interesting here. Buys coming in, needs more volume of course | donald pond | |
26/4/2024 09:01 | strong buying coming in now and gaining good momentum can we see a happy Friday and see this in the high teens this afternoon | citys2874 | |
26/4/2024 08:40 | Suppliers? Again just shows how uneducated you are | zeus19 | |
26/4/2024 07:57 | AZ has thousands of suppliers..a £150k tiny deal doesn't cut the mustard ffs! Shell oil has a massive market cap doesn't mean to say they will buy my car any day soon because it runs on petrol lol! | bones699 | |
26/4/2024 07:27 | Wonderful partnership announced withAstrazeneca a fast growing pharmaceutical company.News on Astrazeneca from ProactiveAs it stands, Astra's market capitalisation is now around £184.61 billion, edging out Shell's £184.57 billion.The pharma giant has enjoyed a spate of upgrades in 2024, with Deutsche Bank analysts highlighting its innovation and growth strategy, and its approach to expansion via bolt-on acquisitions..... | muffster | |
26/4/2024 07:18 | An RNS for a measily £150k...really? Still need to find c.£6m of revenues very soon otherwise its cash placement time! | bones699 | |
26/4/2024 07:10 | Interesting; hxxps://www.theguard | danwaits | |
25/4/2024 13:03 | 'Among the main criticisms from AIM advisers – known as nomads – is that the cost of listing for young, dynamic companies is far too high, about £500,000 at the last count, and that regulations are too tight and onerous.' Are they joking? | arthur_lame_stocks | |
25/4/2024 12:40 | Maybe the 'partners' will come here? | htrocka2 | |
25/4/2024 12:17 | Sad to see what looks like blatant suppression of the share price after such encouraging announcements. UK seems to continually fail to support such an innovative Company in such a demanding therapy area. AN could be well advised to seek a more enlightened overseas partner. | fhmktg | |
25/4/2024 10:54 | Sad sad individual. Nowhere to be seen yesterday though!! | jelenko | |
25/4/2024 09:55 | This just shows how unintelligent you are | zeus19 | |
25/4/2024 09:54 | All you need to read in that statement is ALOT. The best indicator going of a halfwit | inaminute | |
25/4/2024 09:52 | My projected price target back to sub 12p! Alot of hype in yesterday's RNS only one number matters £150k so just another £5.75m to find Newland before the inevitable cash placement following the diasterous financials to be released and chucked on the nearest bonfire! | bones699 | |
25/4/2024 08:56 | ali47fish STG are STRIP TINNING HOLDING LC a leading supplier of specialist connection systems and glass to the automotive sector....Winning big contract have a look. momentum building back up here now at AGL as profit takers gone and buys coming in. | citys2874 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions